AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 53 filers reported holding AERIE PHARMACEUTICALS INC in Q1 2014. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $548,000 | +0.4% | 14,465 | 0.0% | 0.01% | 0.0% |
| Q3 2016 | $546,000 | +109.2% | 14,465 | -2.3% | 0.01% | +100.0% |
| Q2 2016 | $261,000 | +45.0% | 14,809 | 0.0% | 0.00% | +33.3% |
| Q1 2016 | $180,000 | -78.9% | 14,809 | -57.7% | 0.00% | -75.0% |
| Q4 2015 | $853,000 | +16.5% | 35,013 | -15.2% | 0.01% | +20.0% |
| Q3 2015 | $732,000 | +0.4% | 41,290 | 0.0% | 0.01% | +25.0% |
| Q2 2015 | $729,000 | -39.5% | 41,290 | +7.4% | 0.01% | -38.5% |
| Q1 2015 | $1,205,000 | -46.2% | 38,441 | -49.9% | 0.01% | -43.5% |
| Q4 2014 | $2,241,000 | +17.3% | 76,787 | -16.8% | 0.02% | +15.0% |
| Q3 2014 | $1,910,000 | -15.9% | 92,326 | +0.7% | 0.02% | -9.1% |
| Q2 2014 | $2,270,000 | +13.7% | 91,647 | -2.7% | 0.02% | +15.8% |
| Q1 2014 | $1,996,000 | -36.5% | 94,188 | -46.2% | 0.02% | -38.7% |
| Q4 2013 | $3,143,000 | – | 175,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 1,464,749 | $98,944,000 | 34.86% |
| Foresite Capital Management III, LLC | 1,708,046 | $115,379,000 | 24.85% |
| Eversept Partners, LP | 226,902 | $15,327,230 | 7.01% |
| SECTORAL ASSET MANAGEMENT INC | 615,870 | $41,602,000 | 4.65% |
| DAFNA Capital Management LLC | 131,770 | $8,901,000 | 4.17% |
| PACIFIC VIEW ASSET MANAGEMENT, LLC | 68,666 | $4,638,000 | 3.67% |
| Asymmetry Capital Management, L.P. | 49,756 | $3,361,000 | 3.30% |
| PFM Health Sciences, LP | 2,720,218 | $183,751,000 | 2.88% |
| HealthCor Management, L.P. | 1,314,290 | $88,780,000 | 2.82% |
| Boulegeris Investments, Inc. | 66,540 | $4,495,000 | 2.25% |